It is possible that the tumor suppression effect of ADI1 in HCC is mainly manifested through the MTA cycle-mediated increment of SAMe, but might not be so in prostate cancer, because the rate-limiting step for synthesis of SAMe depends on the level of methionine adenosyltransferase in cells. Here, ADI1 is linked to prostate carcinoma.